ArticleACG case reports journal2026
The Role and Efficacy of Plasmapheresis in Acute Liver Failure Due to Hepatitis E Viral Hepatitis.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute liver failure, due to hepatitis E virus (HEV) infection, represents a serious problem in developing countries, lacking access to liver transplantation. Therapeutic plasma exchange has become one potential bridge therapy, which has improved results by elimination of circulating toxins/inflammatory mediators, and ammonia. We describe the clinical course of a 31-year-old man who developed fulminant hepatic failure secondary to HEV infection. After conventional treatment, the patient underwent 5 sessions of plasmapheresis that was associated with marked biochemical and neurological recovery. This case provides support for plasmapheresis as a useful adjunct in the management of HEV-induced acute liver failure and its applicability in resource limited settings where liver transplantation is not available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.